{"name":"Zhang Ying Qian","slug":"zhang-ying-qian","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE82TnJSY1hrNi15UFJ6aDlRME5jc2U3TjlWYmdIbVhNOFZpNV9zazBqQkF2MTJaQUFmSVpXY1pONjRlSUdLbzlVMEE1ZXdocW5WdTRPaWhtMmlTU3NXcWdF?oc=5","date":"2025-01-13","type":"pipeline","source":"Nature","summary":"Application of Artificial Intelligence In Drug-target Interactions Prediction: A Review - Nature","headline":"Application of Artificial Intelligence In Drug-target Interactions Prediction: A Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5xU2wyNlNqcjVoNGRRRERIZmdZdDJDQXZqNkZMZ0ZEV25IT2lGQnN0YlBJV2hxczEtTGpPQk5ZWXlnckI2cmlkVXg4VnhRUGNDM0RnT19NaG5EblpiZkln?oc=5","date":"2023-01-21","type":"pipeline","source":"Nature","summary":"Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I - Nature","headline":"Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9jajhQaXpyN0lHVDEtTGZkajNhVV9LNDBrLXBHVlVrcXQwSmg5Yjc5OVd1N0I1aFpaUHNjbjJGbVUwY0NmZERTX1FIR3JxUExwUm5JRmJfQVpucEk?oc=5","date":"2021-05-12","type":"pipeline","source":"EurekAlert!","summary":"Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes - EurekAlert!","headline":"Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}